Showing results (181-190 of 236) with videos related to
Sort By:
Pageof 24
Frontiers in Immunology|February 3, 2022
G Protein-Coupled Receptor Kinase 2 as Novel Therapeutic Target in Fibrotic DiseasesNan Li, Shan Shan, Xiu-Qin Li, et al.Acta Physiologica (Oxford, England)|October 15, 2024
SUMO: A new perspective to decipher fibrosisLing Li, Ping-Ping Gao, Ting-Ting Chen, et al.Molecular Immunology|May 27, 2014
Daidzein enhances efferocytosis via transglutaminase 2 and augmentation of Rac1 activityJia-Hau Yen, Deng-Jye Yang, Meng-Chi Chen, et al.Oncotargets and Therapy|December 7, 2018
Matched-pair analysis of survival in the patients with T3 laryngeal squamous cell carcinoma treated with supracricoid partial laryngectomy or total laryngectomyXin Xia, Ying-Ying Zhu, Wen-Wen Diao, et al.BMJ Open|March 13, 2024
Qualitative study of challenges with recruitment of hospitals into a cluster controlled trial of clinical decision support in AustraliaMelissa T Baysari, Bethany Annemarie Van Dort, Kristian Stanceski, et al.Zhonghua Wai Ke Za Zhi [Chinese Journal of Surgery]|September 5, 2012
[Experimental study of angiography using vascular interventional robot-2(VIR-2)]Zeng-min Tian, Wang-sheng Lu, Da Liu, et al.Internet Interventions|September 25, 2023
Machine learning identifies a COVID-19-specific phenotype in university students using a mental health appArtur Shvetcov, Alexis Whitton, Suranga Kasturi, et al.Journal of Cancer|January 10, 2022
β-arrestin2 regulating β2-adrenergic receptor signaling in hepatic stellate cells contributes to hepatocellular carcinoma progressionXiu-Qin Li, Wen-Ting Peng, Shan Shan, et al.Acta Pharmacologica Sinica|September 30, 2024
β-arrestin2: an emerging player and potential therapeutic target in inflammatory immune diseasesPing-Ping Gao, Ling Li, Ting-Ting Chen, et al.International Journal of Biological Macromolecules|July 30, 2025
Sirtuin 3, a pivotal actor in liver diseases: research progress and implicationsMeng-Qi Li, Ping-Ping Gao, Nan Li, et al.Pageof 24